Macrophage behavior associated with acute and chronic exposure to HIV gp120, morphine and anandamide: Endothelial implications

International Journal of Cardiology

Volumn 64, Issue SUPPL. 1, 1998, Pages

  Stefano, George B ^a,b   Salzet, Michel ^c   Rialas, Christos M ^a   Mattocks, Dwight ^a   Fimiani, Caterina ^d   Bilfinger, Thomas V ^a,b  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c UNIV LILLE   (France)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Anandamide; Chemokinesis; Chemotaxis; DAME; HIV gp120; IL 1; Macrophages; Morphine

Indexed keywords

ANANDAMIDE; EXCITOTOXIN; GLYCOPROTEIN GP 120; METENKEPHALIN; MORPHINE; N ACETYL S NITROSOPENICILLAMINE; N(G) NITROARGININE; N(G) NITROARGININE METHYL ESTER; NALOXONE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE INHIBITOR; RECOMBINANT INTERLEUKIN 1ALPHA; RIMONABANT;

ARTICLE; CELL ADHESION; CELL MIGRATION; CELL SHAPE; CHEMOKINESIS; CHEMOTAXIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LONG TERM EXPOSURE; MACROPHAGE ACTIVATION; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM; VIRUS LOAD;

ANALYSIS OF VARIANCE; ARACHIDONIC ACIDS; CANNABINOIDS; CELL MOVEMENT; CHEMOTAXIS; DISEASE SUSCEPTIBILITY; ENKEPHALIN, METHIONINE; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HUMANS; INTERLEUKIN-1; MACROPHAGES; MORPHINE; NARCOTICS; NITRIC OXIDE; PENICILLAMINE; POLYUNSATURATED ALKAMIDES;

EID: 0032580215     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(98)00030-8     Document Type: Article

References (56)

1. Peterson PK, Sharp B, Gekker G, Portoghese PS, Sannerud K, Balfour HH. Morphine promotes the growth of HIV-1 in human peripheral blood mononuclear cell cocultures. AIDS 1990;4P:869-73.
2. Peterson PK, Gekker G, Hu S, Anderson WR, Kravitz F, Portoghese PS, Balfour HH, Chao CC. Morphine amplifies HIV-1 expression in chronically infected promonocytes cocultured with human brain cells. J Neuroimmunol 1994;50:167-75.
3. Schweitzer C, Keller F, Schmitt MP, Jaeck D, Adloff M, Schmitt C, Royer C, Kirn A, Aubertin AM. Morphine stimulates HIV replication in primary cultures of human kupffer cells. Res Virol 1991;142:189-95.
4. Chuang LF, Killam Jr. KF, Chuang RY. Increased replication of simian immunodeficiency virus in CEM x 174 cells by morphine sulfate. Biochem Biophys Res Commun 1993;195:1165-73.
5. Donahoe RM. Neuroimmunomodulation by opiates: relationship to HIV-1 infection and AIDS. Adv Neuroimmunol 1993;3:31-46.
6. Stefano GB, Smith EM, Cadet P, Hughes TK. HIV GP120 alteration of DAMA and IL-1a induced chemotaxic responses in human and invertebrate immunocytes. J Neuroimmunol 1993;4:177-84.
7. Stefano GB, Scharrer B, Smith EM, Hughes TK, Magazine HI, Bilfinger TV, Hartman A, Fricchione GL, Liu Y, Makman MH. Opioid and opiate immunoregulatory processes. Crit Rev Immunol 1996;16:109-44.
8. Friedman M, Cepero ML, Klein T, Friedman H. Suppressive effect of δ-9-tetrahydrocannabinol in vitro on phagocytosis by murine macrophages. Proc Soc Exp Biol Med 1986;182:225-8.
9. Lopez-Cepero M, Friedman M, Klein T, Friedman H. Tetrahydrocannabinol-induced suppression of macrophage spreading and phagocytic activity in vitro. J Leukocyte Biol 1986;39:679-86.
10. Specter S, Lancz G, Goodfellow D. Suppression of human macrophage function in vitro by delta-9-tetrahydrocannabinol. J Leukocyte Biol 1991;50:423-6.
11. Devane MA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Mandelbaum A, Etinger A, Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992;258:1946-9.
12. Tang JL, Lancz G, Spector S, Bullock H. Marijuana and immunity: tetrahydrocannabinol-mediated inhibition of growth and phagocytic activity of the murine macrophage cell line, P388D1. Int J Immunopharm 1992;14:253-62.
13. Zheng ZM, Spector S, Friedman H. Inhibition by δ-9-tetrahydrocannabinol of tumor necrosis factor alpha production by mouse and human macrophages. Int J Immunopharm 1992;14:1445-52.
14. Cabral GA, Fischer-Stenger K. Inhibition of macrophage inducible protein expression by δ-9-tetrahydrocannabinol. Life Sci 1994;54:1831-44.
15. Bumette-Curley D, Cabrai GA. Differential inhibition of RAW264.7 macrophage tumoricidal activity by δ-9-tetrahydrocannabinol. Proc Soc Exp Biol Med 1995;210:64-76.
16. McCoy KL, Gainey D, Cabrai GA. δ-9-tetrahydrocannabinol modulates antigen processing by macrophages. J Pharmacol Exp Ther 1995;273:1216-23.
17. Stefano GB, Liu Y, Goligorsky MS. Cannabinoid receptors are coupled to nitric oxide release in invertebrate immunocytes, microglia, and human monocytes. J Biol Chem 1996;271:19238-42.
18. Stefano GB, Bilfinger TV, Fricchione GL. The immune-neuro-link and the macrophage: postcardiotomy delirium, HIV-associated dementia and psychiatry. Prog Neurobiol 1994;42:475-88.
19. Shipp MA, Stefano GB, D'Adamio L, Switzer SN, Howard FD, Sinisterra J, Scharrer B, Reinherz E. Downregulation of enhephalin-mediated inflammatory responses by CD10/neutral endopeptidase 24.11. Nature 1990;347:394-6.
20. Stefano GB, Melchiorri P, Negri L, Hughes TK, Scharrer B. (D-Ala2)-Deltorphin I binding and pharmacological evidence for a special subtype of delta opioid receptor on human and invertebrate immune cells. Proc Natl Acad Sci, USA 1992;89:9316-20.
21. Stefano GB, Bilfinger TV. Human neutrophil and macrophage chemokinesis induced by cardiopulmonary bypass: loss of DAME and IL-1 chemotaxis. J Neuroimmunol 1993;47:189-98.
22. Stefano GB, Digenis A, Spector S, Leung MK, Bilfinger TV, Makman MH, Scharrer B, Abumrad NN. Opiate-like substances in an invertebrate, a novel opiate receptor on invertebrate and human immunocytes, and a role in immunosupression. Proc Natl Acad Sci, USA 1993;90:11099-103.
23. Stefano GB, Hartman A, Bilfinger TV, Magazine HI, Liu Y, Casares F, Goligorsky MS. Presence of the m3 opiate receptor in endothelial cells: coupling to nitric oxide production and vasodilation. J Biol Chem 1995;270:30290-3.
24. Bilfinger TV, Hartman A, Liu Y, Magazine HI, Stefano GB. Cryopreserved veins used for myocardial revascularization: a 5 year experience and a possible mechanism for their increased failure. Ann Thorac Surg 1997;63:1063-9.
25. Magazine HI, Liu Y, Bilfinger TV, Fricchione GL, Stefano GB. Morphine-induced conformational changes in human monocytes, granulocytes, and endothelial cells and in invertebrate immunocytes and microglia are mediated by nitric oxide. J Immunol 1996;156:4845-50.
26. Stefano GB, Salzet M, Magazine HI, Bilfinger TV. Antagonist of LPS and IFN-γ induction of iNOS in human saphenous vein endothelium by morphine and anandamide by nitric oxide inhibition of adenylate cyclase. J Cardiovasc Pharmacol 1998. in press.
27. Gendelman HE, Genis P, Jett M, Zhai Q, Nottet LM. An experimental model system for HIV-1-induced brain injury. Adv Neuroimmunol 1994;4:189-94.
28. Pinegin BV, Saidov MZ, Scheltsyna TL, Gabrilovich DI, Khaitov RM. Peripheral blood neutrophils from HIV-1 infected individuals are armed with factors that cause inhibition of their migration in response to specific antigens. Immunol Lett 1993;36:13-7.
29. Shikant P, Benos DJ, Tang LP, Benveniste EN. HIV glycoprotein 120 enhances intercellular adhesion molecule-1 gene expression in glial cells. Involvement of Janus kinase/signal transducer and activator of transcription and protein kinase C signaling pathways. J Immunol 1996;156:1307-14.
30. Birdsall HH, Trial J, Hallum JA, deJong AL, Green LK, Bandres JC, Smole SC, Laughter AH, Rossen RD. Phenotypic and functional activation of monocytes in HIV-1 infection: interactions with neural cells. J Leukocyte Biol 1994;56:310-7.
31. Chao CC, Sharp BM, Pomeroy C, Filice GA, Peterson PK. Effects of morphine addiction on the pathogenesis of murine toxoplasmosis. Adv Exp Med Biol 1991;288:223-7.
32. Chao CC, Sharp BM, Pomeroy C, Filice GA, Peterson PK. Lethality of morphine in mice infected with Toxoplasma gondii. J Pharmacol Exp Ther 1990;252:605-9.
33. Mintz M. Clinical comparison of adult and pediatric neuroAIDS. Adv Neuroimmunol 1994;4:207-22.
34. Stefano GB, Christensen VB, Tonnesen E, Liu Y, Hughes TK, Bilfinger TV. Interleukin 10 stimulation of endogenous nitric oxide release from human saphenous veins diminishes immunocyte adherence. J Cardiovasc Pharmacol 1997;30:90-5.
35. Stefano GB. Autoimmunovascular regulation:morphine stimulated nitric oxide release. J Neuroimmunol 1998. in press.
36. Karsten V, Gordon S, Kirn A, Herbein G. HIV-1 envelope glycoprotein gp120 down-regulates CD4 expression in primary human macrophages through induction of endogenous tumour necrosis factor-alpha. Immunology 1996;88:55-60.
37. Lipton SA, Yeh M, Dreyer EB. Update on current models of HIV related neuronal injury: platelet-activating factor, arachidonic acid and nitric oxide. Adv Neuroimmunol 1994;4:181-8.
38. Yoshioka M, Bradley WG, Shapshak P, Nasano I, Stewart RV, Xin KQ, Srivastava AK, Nakamura S. Role of immune activation in cytokine expression in HIV-1-associated neurological diseases. Adv Neuroimmunol 1995;5:335-58.
39. Lipton SA. Similarity of neuroanl cell injury and death in AIDS dementia and focal cerebral ischemia: potential treatment with NMDA open-channel blockers and nitric oxide-related species. Brain Pathol 1996;6:507-17.
40. Mollace V, Colasanti M, Rodino P, Lauro GM, Nistico G. HIV coating gp120 glycoprotein-dependent prostaglandin E2 release by human cultured astrocytoma cells is regulated by nitric oxide formation. Biochem Biophys Res Commun 1994;203:87-92.
41. Pietraforte D, Tritarelli E, Testa U, Minetti M. Gp120 HIV envelope glycoprotein increase the production of nitric oxide in human monocyte-derived macrophages. J Leukocyte Biol 1994;55:175-82.
42. Adamson DC, Wildemann B, Sasaki M, Glass JD, McArthur JC, Christov VI, Dawson TM, Dawson VL. Immunologic NO synthase: elevation in severe AIDS dementia and the induction by HIV-1 gp41. Science 1996;274:1917-21.
43. Kong LY, Wilson BC, McMillian MK, Bing G, Hudson PM, Hong JS. The effects of the HIV-1 envelope protein gp120 on the production of nitric oxide and proinflammatory cytokines in mixed glial cell cultures. Cell Immunol 1996;172:77-83.
44. Tabatabaie T, Stewart C, Pye Q, Kotake Y, Floyd RA. In vivo trapping of nitric oxide in the brain of neonatal rats treated with the HIV-1 envelope protein gp120: protective effects of α-phenyl-tertbutylnitrone. Biochem Biophys Res Commun 1996;221:386-90.
45. Corasaniti MT, Melino G, Navarra M, Garaci E, Finazzi-Agro A, Nistico G. Death of cultured human neuroblastoma cells induced by HIV-1 gp120 is prevented by NMDA receptor antagonists and inhibitors of nitric oxide and cyclooxygenase. Neurodegeneration 1995;4:315-21.
46. Koka P, He K, Zack JA, Kitchen S, Peacock W, Fried I, Tran T, Yashar SS, Merrill JE. Human immunodeficiency virus 1 envelope protein induce interleukin 1. tumor necrosis factor-alpha, and nitric oxide in glial cultures derived from fetal, neonatal, and adult human brain. J Exp Med 1995;182:941-51.
47. Dawson VL, Dawson TM, Uhl GR. Human immunodeficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures. Adv Neuroimmunol 1993;90:3256-9.
48. King JM, Srivastava KD, Stefano GB, Bilfinger TV, Bahou WF, Magazine HI. Human monocyte adhesion is modulated by endothelin B receptor-coupled nitric oxide release. J Immunol 1997;158:880-6.
49. Wiley CA, Schreier R, Nelson J, Lampert P, Oldstone M. Cellular localization of human immunodeficiency virus infection within the brains of acquired immunodeficiency syndrome patients. Proc Natl Acad Sci USA 1986;83:7089-93.
50. Koenig S, Gendelman HE, Orenstein J, Del Canto MC, Pezeshkpour G, Yungbluth M, Jenotta F, Akasmit A, Martin MA, Fauci AS. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 1986;233:819-36.
51. Stoler MH, Eskin TA, Benn S, Angerer RC, Angerer LM. Human T-cell lymphotropic virus type III infection of the central nervous system: a preliminary in situ analysis. J Am Med Assoc 1986;256:2360-4.
52. Gabuzda D, Ho DD, de la Monte SM, Hirsch MS, Rota TR, Sobel RA. Immunohistochemical identification of HTLV III antigen in brains of patients with AIDS. Ann Neurol 1986;20:289-95.
53. Moses AV, Nelson JA. HIV infection of human brain capillary endothelial cells-Implication for AIDS dementia. Adv Neuroimmunol 1994;4:239-48.
54. Hurwitz AA, Berman JW, Lyman WD. The role of the blood brain barrier in HIV infection of the central nervous system. Adv Neuroimmunol 1994;4:249-56.
55. Stefano GB, Salzet M, Bilfinger TV. Chronic exposure of human blood vessels to HIV gp120, morphine and anandamide increases endothelial adhesion of monocytes: Uncoupling of nitric oxide release. J Cardiovasc Pharmacol. 1998. in press.
56. Mattocks DW, Salzet M, Salzet B, Stefano GB. Anandamide-induced conformational changes in leech and mussel immunocytes are mediated by nitric oxide. Anim Biol 1998;6:73-7.